88 related articles for article (PubMed ID: 9147418)
1. CD4+ T-cell recognition of diverse clade B HIV-1 isolates.
Fernandez MH; Fidler SJ; Pitman RJ; Weber JN; Rees AD
AIDS; 1997 Mar; 11(3):281-8. PubMed ID: 9147418
[TBL] [Abstract][Full Text] [Related]
2. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
[TBL] [Abstract][Full Text] [Related]
3. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.
Ratto S; Sitz KV; Scherer AM; Loomis LD; Cox JH; Redfield RR; Birx DL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):128-36. PubMed ID: 8556394
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells from HIV-1-infected patients naturally express HIV-1 gp120 V3 loop-derived peptide ligands.
Fernandez MH; Pitman RJ; Hawrylowicz CM; Rees AD
Eur J Immunol; 1998 Oct; 28(10):3144-53. PubMed ID: 9808183
[TBL] [Abstract][Full Text] [Related]
6. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells.
Trujillo JR; Rogers RA; Brain JD
Virology; 1998 Jun; 246(1):53-62. PubMed ID: 9656993
[TBL] [Abstract][Full Text] [Related]
7. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.
Safrit JT; Lee AY; Andrews CA; Koup RA
J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505
[TBL] [Abstract][Full Text] [Related]
8. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
Warren AP; Thomas DB
AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals.
Nehete PN; Johnson PC; Schapiro SJ; Arlinghaus RB; Sastry KJ
J Clin Immunol; 1996 Mar; 16(2):115-24. PubMed ID: 8690775
[TBL] [Abstract][Full Text] [Related]
10. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
11. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
Bures R; Morris L; Williamson C; Ramjee G; Deers M; Fiscus SA; Abdool-Karim S; Montefiori DC
J Virol; 2002 Mar; 76(5):2233-44. PubMed ID: 11836401
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.
Bartlett JA; Wasserman SS; Hicks CB; Dodge RT; Weinhold KJ; Tacket CO; Ketter N; Wittek AE; Palker TJ; Haynes BF
AIDS; 1998 Jul; 12(11):1291-300. PubMed ID: 9708408
[TBL] [Abstract][Full Text] [Related]
13. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
Zolla-Pazner S; Zhong P; Revesz K; Volsky B; Williams C; Nyambi P; Gorny MK
AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1254-8. PubMed ID: 15588347
[TBL] [Abstract][Full Text] [Related]
14. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.
Botarelli P; Houlden BA; Haigwood NL; Servis C; Montagna D; Abrignani S
J Immunol; 1991 Nov; 147(9):3128-32. PubMed ID: 1717587
[TBL] [Abstract][Full Text] [Related]
15. Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.
Peifang S; Pira GL; Fenoglio D; Harris S; Costa MG; Venturino V; Dessì V; Layton G; Laman J; Huisman JG
Clin Exp Immunol; 1994 Sep; 97(3):361-6. PubMed ID: 7915974
[TBL] [Abstract][Full Text] [Related]
16. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones.
Fidler SJ; Dorrell L; Ball S; Lombardi G; Weber J; Hawrylowicz C; Rees AD
Immunology; 1996 Sep; 89(1):46-53. PubMed ID: 8911139
[TBL] [Abstract][Full Text] [Related]
17. Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.
Vancott TC; Polonis VR; Loomis LD; Michael NL; Nara PL; Birx DL
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1379-91. PubMed ID: 8573396
[TBL] [Abstract][Full Text] [Related]
18. Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.
Norris PJ; Moffett HF; Brander C; Allen TM; O'Sullivan KM; Cosimi LA; Kaufmann DE; Walker BD; Rosenberg ES
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):315-25. PubMed ID: 15117455
[TBL] [Abstract][Full Text] [Related]
19. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.
Gorny MK; Mascola JR; Israel ZR; VanCott TC; Williams C; Balfe P; Hioe C; Brodine S; Burda S; Zolla-Pazner S
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):213-21. PubMed ID: 9491911
[TBL] [Abstract][Full Text] [Related]
20. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
